Cargando…

Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data

The advent of next generation sequencing technologies (NGS) has expanded the area of genomic research, offering high coverage and increased sensitivity over older microarray platforms. Although the current cost of next generation sequencing is still exceeding that of microarray approaches, the rapid...

Descripción completa

Detalles Bibliográficos
Autores principales: McArt, Darragh G., Dunne, Philip D., Blayney, Jaine K., Salto-Tellez, Manuel, Van Schaeybroeck, Sandra, Hamilton, Peter W., Zhang, Shu-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694114/
https://www.ncbi.nlm.nih.gov/pubmed/23840550
http://dx.doi.org/10.1371/journal.pone.0066902
_version_ 1782274812621619200
author McArt, Darragh G.
Dunne, Philip D.
Blayney, Jaine K.
Salto-Tellez, Manuel
Van Schaeybroeck, Sandra
Hamilton, Peter W.
Zhang, Shu-Dong
author_facet McArt, Darragh G.
Dunne, Philip D.
Blayney, Jaine K.
Salto-Tellez, Manuel
Van Schaeybroeck, Sandra
Hamilton, Peter W.
Zhang, Shu-Dong
author_sort McArt, Darragh G.
collection PubMed
description The advent of next generation sequencing technologies (NGS) has expanded the area of genomic research, offering high coverage and increased sensitivity over older microarray platforms. Although the current cost of next generation sequencing is still exceeding that of microarray approaches, the rapid advances in NGS will likely make it the platform of choice for future research in differential gene expression. Connectivity mapping is a procedure for examining the connections among diseases, genes and drugs by differential gene expression initially based on microarray technology, with which a large collection of compound-induced reference gene expression profiles have been accumulated. In this work, we aim to test the feasibility of incorporating NGS RNA-Seq data into the current connectivity mapping framework by utilizing the microarray based reference profiles and the construction of a differentially expressed gene signature from a NGS dataset. This would allow for the establishment of connections between the NGS gene signature and those microarray reference profiles, alleviating the associated incurring cost of re-creating drug profiles with NGS technology. We examined the connectivity mapping approach on a publicly available NGS dataset with androgen stimulation of LNCaP cells in order to extract candidate compounds that could inhibit the proliferative phenotype of LNCaP cells and to elucidate their potential in a laboratory setting. In addition, we also analyzed an independent microarray dataset of similar experimental settings. We found a high level of concordance between the top compounds identified using the gene signatures from the two datasets. The nicotine derivative cotinine was returned as the top candidate among the overlapping compounds with potential to suppress this proliferative phenotype. Subsequent lab experiments validated this connectivity mapping hit, showing that cotinine inhibits cell proliferation in an androgen dependent manner. Thus the results in this study suggest a promising prospect of integrating NGS data with connectivity mapping.
format Online
Article
Text
id pubmed-3694114
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36941142013-07-09 Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data McArt, Darragh G. Dunne, Philip D. Blayney, Jaine K. Salto-Tellez, Manuel Van Schaeybroeck, Sandra Hamilton, Peter W. Zhang, Shu-Dong PLoS One Research Article The advent of next generation sequencing technologies (NGS) has expanded the area of genomic research, offering high coverage and increased sensitivity over older microarray platforms. Although the current cost of next generation sequencing is still exceeding that of microarray approaches, the rapid advances in NGS will likely make it the platform of choice for future research in differential gene expression. Connectivity mapping is a procedure for examining the connections among diseases, genes and drugs by differential gene expression initially based on microarray technology, with which a large collection of compound-induced reference gene expression profiles have been accumulated. In this work, we aim to test the feasibility of incorporating NGS RNA-Seq data into the current connectivity mapping framework by utilizing the microarray based reference profiles and the construction of a differentially expressed gene signature from a NGS dataset. This would allow for the establishment of connections between the NGS gene signature and those microarray reference profiles, alleviating the associated incurring cost of re-creating drug profiles with NGS technology. We examined the connectivity mapping approach on a publicly available NGS dataset with androgen stimulation of LNCaP cells in order to extract candidate compounds that could inhibit the proliferative phenotype of LNCaP cells and to elucidate their potential in a laboratory setting. In addition, we also analyzed an independent microarray dataset of similar experimental settings. We found a high level of concordance between the top compounds identified using the gene signatures from the two datasets. The nicotine derivative cotinine was returned as the top candidate among the overlapping compounds with potential to suppress this proliferative phenotype. Subsequent lab experiments validated this connectivity mapping hit, showing that cotinine inhibits cell proliferation in an androgen dependent manner. Thus the results in this study suggest a promising prospect of integrating NGS data with connectivity mapping. Public Library of Science 2013-06-26 /pmc/articles/PMC3694114/ /pubmed/23840550 http://dx.doi.org/10.1371/journal.pone.0066902 Text en © 2013 McArt et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
McArt, Darragh G.
Dunne, Philip D.
Blayney, Jaine K.
Salto-Tellez, Manuel
Van Schaeybroeck, Sandra
Hamilton, Peter W.
Zhang, Shu-Dong
Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data
title Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data
title_full Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data
title_fullStr Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data
title_full_unstemmed Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data
title_short Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data
title_sort connectivity mapping for candidate therapeutics identification using next generation sequencing rna-seq data
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694114/
https://www.ncbi.nlm.nih.gov/pubmed/23840550
http://dx.doi.org/10.1371/journal.pone.0066902
work_keys_str_mv AT mcartdarraghg connectivitymappingforcandidatetherapeuticsidentificationusingnextgenerationsequencingrnaseqdata
AT dunnephilipd connectivitymappingforcandidatetherapeuticsidentificationusingnextgenerationsequencingrnaseqdata
AT blayneyjainek connectivitymappingforcandidatetherapeuticsidentificationusingnextgenerationsequencingrnaseqdata
AT saltotellezmanuel connectivitymappingforcandidatetherapeuticsidentificationusingnextgenerationsequencingrnaseqdata
AT vanschaeybroecksandra connectivitymappingforcandidatetherapeuticsidentificationusingnextgenerationsequencingrnaseqdata
AT hamiltonpeterw connectivitymappingforcandidatetherapeuticsidentificationusingnextgenerationsequencingrnaseqdata
AT zhangshudong connectivitymappingforcandidatetherapeuticsidentificationusingnextgenerationsequencingrnaseqdata